Your browser doesn't support javascript.
loading
CD70 is a potential target biomarker in peripheral T-cell lymphomas.
Marques-Piubelli, Mario L; Sagert, Jason; Pham, Minh Thu; Will, Matthias; Henderson, Dan; Tipton, Kimberly; Iyer, Swaminathan; Lu, Wei; Khan, Khaja B; Hamana, Leticia; Chapman, Jennifer R; Thakral, Beenu; Xu, Jie; Miranda, Roberto N; Jennings, Kristofer; Solis, Luisa M; Vega, Francisco.
Afiliação
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Sagert J; CRISPR Therapeutics, Zug, Switzerland.
  • Pham MT; CRISPR Therapeutics, Zug, Switzerland.
  • Will M; CRISPR Therapeutics, Zug, Switzerland.
  • Henderson D; CRISPR Therapeutics, Zug, Switzerland.
  • Tipton K; CRISPR Therapeutics, Zug, Switzerland.
  • Iyer S; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Lu W; Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Khan KB; Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Hamana L; Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Chapman JR; Department of Pathology and Laboratory Medicine, University of Miami/Jackson Memorial Hospital, Miami, FL, USA.
  • Thakral B; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Xu J; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Miranda RN; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Jennings K; Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Solis LM; Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Vega F; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Histopathology ; 81(2): 272-275, 2022 08.
Article em En | MEDLINE | ID: mdl-35474464

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article